The characteristics of non-alcoholic fatty liver disease and its associated factors in patients with rheumatoid arthritis.
10.3760/cma.j.cn112150-20210706-00647
- Author:
Tao WU
1
;
Yao Wei ZOU
1
;
Jian Da MA
1
;
Chu Tao CHEN
1
;
Xue Pei ZHANG
1
;
Jian Zi LIN
1
;
Yan Hui XU
1
;
Kui Min YANG
1
;
Qian ZHANG
1
;
Yao Yao ZOU
1
;
Ying Qian MO
1
;
Lie DAI
1
Author Information
1. Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Arthritis, Rheumatoid/epidemiology*;
Cholesterol, LDL;
Cross-Sectional Studies;
Female;
Humans;
Male;
Middle Aged;
Non-alcoholic Fatty Liver Disease/epidemiology*;
Obesity/epidemiology*;
Overweight/epidemiology*;
Triglycerides;
Young Adult
- From:
Chinese Journal of Preventive Medicine
2022;56(5):574-582
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the characteristics of non-alcoholic fatty liver disease (NAFLD) and its associated factors in rheumatoid arthritis (RA) patients. Methods: This cross-sectional study recruited 385 RA patients [including 72 (18.7%) male and 313 (81.3%) female] who received abdominal sonographic examination from August 2015 to May 2021 at Department of Rheumatology, Sun Yat-Sen Memorial Hospital. There were 28 RA patients at 16-29 years old and 32, 80, 121, 99, 25 at 30-39, 40-49, 50-59, 60-69, ≥ 70 years old, respectively. Demographic and clinical data were collected including age, gender, history of alcohol consumption, disease duration, body mass index (BMI), waist circumference, blood pressure, RA disease activity indicators and previous medications. Logistic regression analyses were used to identify the associated factors of NAFLD in RA patients. Results: The prevalence of NAFLD was 24.2% (93/385) in RA patients, 26.3% (21/80) in 40-49 age group and 33.1% (40/121) in 50-59 age group. There were 22.1% (85/385) and 3.6% (14/385) RA patients with overweight and obese, in which the prevalence of NAFLD was 45.9% (39/85) and 78.6% (11/14) respectively, which was 2.6 folds and 4.5 folds that of RA patients with normal BMI. Although there was no significant difference of age, gender and RA disease activity indicators between RA patients with or without NAFLD, those with NAFLD had higher proportions of metabolic diseases including obese (11.8% vs. 1.0%), central obesity (47.3% vs. 16.8%), hypertension (45.2% vs. 29.8%) and type 2 diabetes mellitus (24.7% vs. 12.0%), consistent with higher levels of total cholesterol [(5.33±1.31) mmol/L vs. (4.73±1.12) mmol/L], triglyceride [(1.51±1.08) mmol/L vs. (0.98±0.54) mmol/L] and low-density lipoprotein cholesterol [(3.37±0.97) mmol/L vs. (2.97±0.78) mmol/L, all P<0.05]. Multivariate logistic regression analysis showed that BMI (OR=1.314) and triglyceride (OR=1.809) were the independent factors positively associated with NAFLD in RA patients. Conclusion: NAFLD is a common comorbidity in RA patients, especially in those with middle-aged, overweight or obese, which is associated with high BMI or high triglyceride. Screening and management of NAFLD in RA patients especially those with overweight, obese or dyslipidemia should be emphasized.
